ArticleIBRO neuroscience reports2025
Hippocampal dorsal CA1: Functional connectivity and role in HCN channelopathies in affective diseases and epilepsy.
Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hippocampus is a complex structure consisting of the dentate gyrus (DG), cornu ammonis (CA) and the subiculum. CA1 is further subdivided into the ventral (vCA1) and dorsal (dCA1) compartments, with dCA1 believed to be crucial in spatial learning and memory as well as cognitive processing. Although dCA1 was traditionally thought to be not likely relevant to affective diseases, recent studies suggest otherwise. In fact, it has been found that diseases including certain types of post-traumatic stress disorder (PTSD), depression and epilepsy may be attributed to channelopathies in dCA1, particularly that of hyperpolarization-activated cyclic nucleotide gated (HCN) channels. However, it remains unclear how disruptions of HCN transcription, post-transcriptional modification and activation kinetics are related to changes of downstream structures along neural circuits. Their effect on behavioural changes and disease development, as well as the corresponding potential therapeutic strategies implicated in the findings have not been extensively studied as well. With the existing research gap and the significant clinical implications of dCA1 HCN channelopathies, the mechanisms of how defects of these channels result in brain disorders including PTSD, depression and temporal lobe epilepsy are worthy of further investigation. Therefore, in this review, we summarize the recent findings on the involvement of dCA1 HCN channelopathies in brain disorders after providing an outline on the neuroanatomy and functional connectivity of dCA1, and the features of HCN channels in that region. We also propose future directions of molecular and systems neuroscience studies, as well as the translational research on potential therapeutics that address the brain disorders related to dCA1 HCN channelopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.